BRPI0416812A - métodos e reagentes para o tratamento de desordens inflamatórias - Google Patents
métodos e reagentes para o tratamento de desordens inflamatóriasInfo
- Publication number
- BRPI0416812A BRPI0416812A BRPI0416812-7A BRPI0416812A BRPI0416812A BR PI0416812 A BRPI0416812 A BR PI0416812A BR PI0416812 A BRPI0416812 A BR PI0416812A BR PI0416812 A BRPI0416812 A BR PI0416812A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- reagents
- methods
- inflammatory disorders
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"MéTODOS E REAGENTES PARA O TRATAMENTO DE DESORDENS INFLAMATóRIAS". A presente invenção refere-se a um método para tratar um imunoinflamatório administrando um composto de fórmula (I), por exemplo, ibudilast ou KC-764, sozinho ou em combinação com um corticosteróide, pirimidopirimidina tetra-substituída, ou outro composto. A invenção também apresenta composições farmacêuticas incluindo a combinação acima para o tratamento ou prevenção de uma desordem imunoinflamatória.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52411703P | 2003-11-21 | 2003-11-21 | |
PCT/US2004/038512 WO2005051293A2 (en) | 2003-11-21 | 2004-11-17 | Methods and reagents for the treatment of inflammatory disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0416812A true BRPI0416812A (pt) | 2007-03-06 |
Family
ID=34632866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0416812-7A BRPI0416812A (pt) | 2003-11-21 | 2004-11-17 | métodos e reagentes para o tratamento de desordens inflamatórias |
Country Status (17)
Country | Link |
---|---|
US (2) | US7709495B2 (pt) |
EP (1) | EP1689390B1 (pt) |
JP (1) | JP2007512337A (pt) |
KR (1) | KR20060120208A (pt) |
CN (1) | CN1905870A (pt) |
AT (1) | ATE497763T1 (pt) |
AU (1) | AU2004292445B2 (pt) |
BR (1) | BRPI0416812A (pt) |
CA (1) | CA2546347A1 (pt) |
DE (1) | DE602004031356D1 (pt) |
IL (1) | IL175781A0 (pt) |
NO (1) | NO20062300L (pt) |
NZ (1) | NZ547389A (pt) |
RU (1) | RU2006121978A (pt) |
SG (1) | SG148198A1 (pt) |
WO (1) | WO2005051293A2 (pt) |
ZA (1) | ZA200604253B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1689390B1 (en) * | 2003-11-21 | 2011-02-09 | Zalicus Inc. | Methods and reagents for the treatment of inflammatory disorders |
MX2007006777A (es) | 2004-12-06 | 2007-08-06 | Avigen Inc | Ibudilast para tratar dolor neuropatico y sindromes asociados. |
AR054249A1 (es) * | 2005-04-13 | 2007-06-13 | Astion Dev As | Tratamiento de enfermedades del tejido conectivo de la piel |
JP2009524590A (ja) * | 2005-12-20 | 2009-07-02 | ティカ レーケメデル アーベー | 薬物動態学的プロフィールの向上を有するコルチコステロイドを送達するための方法およびシステム |
KR20080089512A (ko) * | 2006-01-26 | 2008-10-06 | 콤비네이토릭스, 인코포레이티드 | 근골격계 질환 및 이와 관련된 증상을 치료하기 위한 방법,조성물 및 키트 |
CA2653345A1 (en) * | 2006-05-31 | 2007-12-13 | Avigen, Inc. | Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
JP5352452B2 (ja) * | 2006-06-06 | 2013-11-27 | メディシノバ, インコーポレイテッド | 置換ピラゾロ[1,5−a]ピリジン化合物およびその使用方法 |
US7536799B2 (en) * | 2007-06-07 | 2009-05-26 | Keson Industries | Chalk line apparatus with strategically located chalk fill opening |
US20090005358A1 (en) * | 2007-06-26 | 2009-01-01 | Jan Lessem | Compositions and methods for treating medical conditions |
PL2187882T3 (pl) * | 2007-07-11 | 2013-05-31 | Medicinova Inc | Leczenie postępującej choroby neurodegeneracyjnej ibudilastem |
GB201305714D0 (en) * | 2013-03-28 | 2013-05-15 | Ucl Business Plc | Method |
RU2536274C1 (ru) * | 2013-12-20 | 2014-12-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ лечения бородавок |
CN108033959A (zh) * | 2018-01-29 | 2018-05-15 | 山东省药学科学院 | 一种异丁司特的化学合成方法 |
WO2019226515A1 (en) * | 2018-05-21 | 2019-11-28 | The University Of North Carolina At Chapel Hill | Methods of inhibiting proinflammatory neuroimmune signaling and treating inflammatory disorders |
CN113456618A (zh) * | 2020-03-31 | 2021-10-01 | 天津金耀集团有限公司 | 一种复方双嘧达莫的吸入制剂及其制备方法 |
EP4132521A1 (en) * | 2020-04-06 | 2023-02-15 | MediciNova, Inc. | Methods of reducing plasma level of macrophage migratory inhibitory factor in patients with ibudilast |
EP4284366A1 (en) * | 2021-01-29 | 2023-12-06 | MediciNova, Inc. | Methods of treating chemical gas exposure |
CN115414354A (zh) * | 2022-08-29 | 2022-12-02 | 西南医科大学 | 花椒毒素在制备治疗血小板减少症药物中的应用 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US532248A (en) | 1895-01-08 | powell | ||
JPS5229318B2 (pt) | 1972-03-30 | 1977-08-01 | ||
US4097483A (en) | 1974-11-01 | 1978-06-27 | Kyorin Pharmaceutical Co., Ltd. | Pyrazolo 1,5-a!pyridines |
SE445174B (sv) | 1978-03-07 | 1986-06-09 | Sandoz Ag | Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans |
JPS59167590A (ja) | 1983-03-14 | 1984-09-21 | Kyorin Pharmaceut Co Ltd | ピラゾロ〔1,5−a〕ピリジン誘導体、その製法及びそれを含有する治療剤 |
US4894366A (en) | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
US5639724A (en) | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
US5254562A (en) | 1984-12-03 | 1993-10-19 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
JP2577049B2 (ja) | 1987-06-04 | 1997-01-29 | 三共株式会社 | シクロスポリン製剤 |
US4925849A (en) | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
JPH01153634A (ja) * | 1987-12-10 | 1989-06-15 | Kyorin Pharmaceut Co Ltd | 吸入剤 |
US5342625A (en) | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
GB2222770B (en) | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
US6007840A (en) | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
US5208228A (en) | 1989-11-13 | 1993-05-04 | Merck & Co., Inc. | Aminomacrolides and derivatives having immunosuppressive activity |
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5143918A (en) | 1990-10-11 | 1992-09-01 | Merck & Co., Inc. | Halomacrolides and derivatives having immunosuppressive activity |
US5626863A (en) | 1992-02-28 | 1997-05-06 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5250678A (en) | 1991-05-13 | 1993-10-05 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity |
US5262533A (en) | 1991-05-13 | 1993-11-16 | Merck & Co., Inc. | Amino O-aryl macrolides having immunosuppressive activity |
US5162334A (en) | 1991-05-13 | 1992-11-10 | Merck & Co., Inc. | Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity |
US5189042A (en) | 1991-08-22 | 1993-02-23 | Merck & Co. Inc. | Fluoromacrolides having immunosuppressive activity |
US5208241A (en) | 1991-09-09 | 1993-05-04 | Merck & Co., Inc. | N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity |
WO1993015740A1 (en) * | 1992-02-07 | 1993-08-19 | Kligman Albert M | Methods of treating inflammatory dermatoses |
US5284840A (en) | 1992-06-12 | 1994-02-08 | Merck & Co., Inc. | Alkylidene macrolides having immunosuppressive activity |
US6022852A (en) | 1993-10-22 | 2000-02-08 | Hexal Ag | Pharmaceutical composition containing cyclosporin A |
US5693648A (en) | 1994-09-30 | 1997-12-02 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity |
US5688810A (en) | 1994-12-22 | 1997-11-18 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
DE69635048T2 (de) * | 1995-06-12 | 2006-02-16 | G.D. Searle & Co. | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
JPH0920663A (ja) * | 1995-07-07 | 1997-01-21 | Teikoku Seiyaku Co Ltd | イブジラストを含有する徐放性細粒剤およびその製法 |
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
JPH11222425A (ja) * | 1997-10-27 | 1999-08-17 | Ss Pharmaceut Co Ltd | 関節疾患治療用関節内投与製剤 |
US6372779B1 (en) | 1997-12-29 | 2002-04-16 | Ortho Pharmaceutical Corporation | Anti-inflammatory compounds |
US5900249A (en) | 1998-02-09 | 1999-05-04 | Smith; David J. | Multicomponent pain relief topical medication |
US6506766B1 (en) | 1998-02-13 | 2003-01-14 | Abbott Laboratories | Glucocortiocoid-selective antinflammatory agents |
US6380207B2 (en) | 1998-02-13 | 2002-04-30 | Abbott Laboratories | Glucocortiocoid-selective antiinflammatory agents |
JP4828003B2 (ja) * | 1998-08-10 | 2011-11-30 | 杏林製薬株式会社 | 多発性硬化症治療薬 |
AU2354700A (en) * | 1998-12-11 | 2000-06-26 | Biomira Inc. | Muc-1 antagonists and methods of treating immune disorders |
JP2000212021A (ja) * | 1999-01-14 | 2000-08-02 | Pola Chem Ind Inc | 皮膚外用剤 |
UA74145C2 (uk) | 1999-04-30 | 2005-11-15 | Пфайзер Продактс Інк. | Модулятори глюкокортикоїдного рецептора |
TR200103271T2 (tr) * | 1999-05-14 | 2002-06-21 | The Regents Of The University Of California | İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi. |
US6593480B2 (en) | 1999-09-01 | 2003-07-15 | Abbott Laboratories | Glucocorticoid receptor antagonists for treatment of diabetes |
IL180679A0 (en) | 2000-10-27 | 2009-02-11 | Pfizer Prod Inc | Process for the preparation of non-steroidal glucocorticoid receptor modulators |
EP1201649B1 (en) | 2000-10-28 | 2006-05-31 | Pfizer Products Inc. | Glucocorticoid receptor modulators |
JP2003055220A (ja) * | 2001-08-09 | 2003-02-26 | Taisho Pharmaceut Co Ltd | イブジラスト含有眼科用組成物 |
JP2003055222A (ja) * | 2001-08-16 | 2003-02-26 | Rohto Pharmaceut Co Ltd | 安定化された組成物 |
JP4745609B2 (ja) | 2002-01-22 | 2011-08-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | グルココルチコイドレセプターのための非ステロイド性リガンド、その組成物および使用 |
US20050192261A1 (en) * | 2003-09-15 | 2005-09-01 | Jost-Price Edward R. | Methods and reagents for the treatment of immunoinflammatory disorders |
TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
EP1689390B1 (en) * | 2003-11-21 | 2011-02-09 | Zalicus Inc. | Methods and reagents for the treatment of inflammatory disorders |
-
2004
- 2004-11-17 EP EP04811275A patent/EP1689390B1/en active Active
- 2004-11-17 CN CNA2004800408087A patent/CN1905870A/zh active Pending
- 2004-11-17 RU RU2006121978/15A patent/RU2006121978A/ru not_active Application Discontinuation
- 2004-11-17 BR BRPI0416812-7A patent/BRPI0416812A/pt not_active IP Right Cessation
- 2004-11-17 AU AU2004292445A patent/AU2004292445B2/en not_active Ceased
- 2004-11-17 JP JP2006541339A patent/JP2007512337A/ja active Pending
- 2004-11-17 WO PCT/US2004/038512 patent/WO2005051293A2/en active Application Filing
- 2004-11-17 DE DE602004031356T patent/DE602004031356D1/de active Active
- 2004-11-17 CA CA002546347A patent/CA2546347A1/en not_active Abandoned
- 2004-11-17 SG SG200808670-4A patent/SG148198A1/en unknown
- 2004-11-17 ZA ZA200604253A patent/ZA200604253B/xx unknown
- 2004-11-17 KR KR1020067012128A patent/KR20060120208A/ko not_active Application Discontinuation
- 2004-11-17 NZ NZ547389A patent/NZ547389A/en unknown
- 2004-11-17 AT AT04811275T patent/ATE497763T1/de not_active IP Right Cessation
- 2004-11-19 US US10/992,878 patent/US7709495B2/en not_active Expired - Fee Related
-
2006
- 2006-05-18 IL IL175781A patent/IL175781A0/en unknown
- 2006-05-22 NO NO20062300A patent/NO20062300L/no not_active Application Discontinuation
-
2010
- 2010-05-03 US US12/772,693 patent/US20100210606A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20100210606A1 (en) | 2010-08-19 |
EP1689390B1 (en) | 2011-02-09 |
ZA200604253B (en) | 2007-10-31 |
RU2006121978A (ru) | 2007-12-27 |
CN1905870A (zh) | 2007-01-31 |
NO20062300L (no) | 2006-08-21 |
AU2004292445B2 (en) | 2010-02-04 |
IL175781A0 (en) | 2008-04-13 |
EP1689390A2 (en) | 2006-08-16 |
DE602004031356D1 (de) | 2011-03-24 |
EP1689390A4 (en) | 2008-03-12 |
WO2005051293A2 (en) | 2005-06-09 |
ATE497763T1 (de) | 2011-02-15 |
NZ547389A (en) | 2009-11-27 |
US20050187203A1 (en) | 2005-08-25 |
AU2004292445A1 (en) | 2005-06-09 |
JP2007512337A (ja) | 2007-05-17 |
CA2546347A1 (en) | 2005-06-09 |
SG148198A1 (en) | 2008-12-31 |
WO2005051293A3 (en) | 2006-03-02 |
KR20060120208A (ko) | 2006-11-24 |
US7709495B2 (en) | 2010-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062300L (no) | Fremgangsmater og reagenser for behandling av inflammatoriske forstyrelser | |
CY1116754T1 (el) | Παραγωγα νιτροκατεχολης ως αναστολεις της comt | |
CY1121135T1 (el) | Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος | |
TW200517114A (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
EA201270184A1 (ru) | Лечение расстройств печени ингибиторами pi3k | |
UA118645C2 (uk) | Спосіб комбінованої терапії раку наночастинками, що містять рапаміцин і альбумін | |
CY1112238T1 (el) | Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων | |
BRPI0512500A (pt) | tratamento ou condições envolvendo desmielinação | |
AU2003256755A8 (en) | Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations | |
EA200700333A1 (ru) | Терапевтические применения ингибиторов rtp801 | |
AR047841A1 (es) | Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios | |
WO2007070052A3 (en) | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease | |
BRPI0413326A (pt) | métodos para tratar doença cardiovasculares empregando-se uma molécula ctla4 solúvel | |
WO2007103373A3 (en) | Compositions and methods for the treatment of immunoinflammatory disorders | |
BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
DE602004032522D1 (de) | Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung | |
DK1948155T3 (da) | Farmaceutiske præparater omfattende droxidopa | |
TW200740441A (en) | Methods and reagents for the treatment of inflammatory disorders | |
EA200801120A1 (ru) | Нафтильные производные в качестве ингибиторов агрегирования бета-амилоида | |
ATE466595T1 (de) | Verbindungen und methoden für das downregulating der effekte von tgf-beta | |
SG148186A1 (en) | Methods and reagents for the treatment of inflammatory disorders | |
CR9200A (es) | Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos | |
TW200716561A (en) | P38 inhibitors and methods of use thereof | |
WO2008021048A3 (en) | Adp-ribosyltransferase based methods and compositions | |
CY1110368T1 (el) | Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 8A E 9A ANUIDADES. |
|
B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 8A, 9A, 10A, 11A, 12A, 13A, 14A E 15A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |